Patient-Reported Outcomes and Complications After Structural Rhinoplasty Using Septal Extension Grafts

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCumhuriyet University Hospital

About this trial

Structural rhinoplasty with septal extension graft (SEG) is commonly used to achieve stable nasal tip support and predictable long-term outcomes. However, surgical success is not limited to structural stability alone and should also be evaluated from the patient's perspective.

Patient-reported outcome measures (PROMs) have gained increasing importance in rhinoplasty, as they reflect patient satisfaction and perceived nasal function. Despite the widespread use of SEG, prospective studies evaluating PROMs together with postoperative clinical findings over time remain limited.

This prospective observational cohort study aims to evaluate longitudinal changes in patient-reported outcomes and postoperative findings in adult patients undergoing primary structural rhinoplasty with SEG-based nasal tip support. Validated PROM instruments will be applied preoperatively and during routine postoperative follow-up visits at approximately 1, 3, and 6 months.

In addition, postoperative complications and revision procedures will be recorded. The study aims to provide a more comprehensive understanding of patient-centered outcomes and their relationship with clinical findings in SEG-based rhinoplasty.

Eligibility criteria

Qualifiers

Age 18 years or older

Undergoing primary structural rhinoplasty with septal extension graft

Able to understand and complete patient-reported outcome questionnaires (PROMs)

Willing to participate and provide written informed consent

Disqualifiers

History of previous nasal surgery (revision rhinoplasty)

Undergoing concomitant major craniofacial procedures

Missing preoperative PROM data

Unable to complete postoperative follow-up assessments

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

50 Participants
are grouped into 1 trial group

Sponsors and collaborators